Table 1.
Baseline Clinical and Demographic Characteristics of Younger and Older Patients
| Younger women (<70) n=237 |
Older women (≥ 70) n=90 |
P-value | |
|---|---|---|---|
| Age – median (IQR) | 61 (11) | 74 (5) | <0.01 |
| Race | 0.06 | ||
| White | 210 (88.6) | 86 (95.6) | |
| Non-white | 27 (11.4) | 4 (4.4) | |
| Body mass index | 0.56 | ||
| Non-overweight | 71 (30.0) | 26 (28.9) | |
| Overweight | 91 (38.4) | 40 (44.4) | |
| Obese | 75 (31.7) | 24 (26.7) | |
| Parity – median (IQR) | 2 (1) | 3 (2) | <0.01 |
| Number of vaginal deliveries | <0.01 | ||
| 0 | 8 (3.8) | 4 (5.0) | |
| 1 or 2 | 137 (65.2) | 35 (43.8) | |
| ≥ 3 | 65 (31.0) | 41 (51.3) | |
| Post-menopausal | 216 (92.0) | 90 (100) | <0.01 |
| Medical comorbidities | |||
| Hypertension | 98 (41.4) | 57 (63.3) | <0.01 |
| Diabetes Mellitus | 19 (8.0) | 6 (6.7) | 0.68 |
| COPD or Asthma | 23 (9.7) | 12 (13.3) | 0.34 |
| Ever tobacco use | 60 (25.3) | 25 (27.8) | 0.65 |
| Previous pelvic surgery | |||
| Hysterectomy | 144 (60.8) | 60 (66.7) | 0.32 |
| Urinary incontinence procedure | 39 (16.5) | 22 (24.4) | 0.10 |
| Anterior repair | 22 (9.3) | 13 (14.4) | 0.18 |
| Posterior repair | 19 (8.0) | 16 (17.8) | 0.01 |
| Preoperative vaginal hormone replacement therapy | 168 (70.9) | 80 (88.9) | <0.01 |
| POP-Q measurements – median (IQR) | |||
| Ba | 1 (2) | 2 (3) | 0.07 |
| Bp | −1 (2) | −1 (4) | 0.20 |
| C | −3 (4) | −2 (5.5) | 0.99 |
| TVL | 10 (1.5) | 10 (2) | 0.18 |
| POP-Q Stage | 0.09 | ||
| 2 | 134 (57.0) | 39 (43.3) | |
| 3 | 83 (35.3) | 42 (46.7) | |
| 4 | 18 (7.7) | 9 (10.0) | |
| Baseline Quality of Life measures – median (IQR) | |||
| PFDI-20 | 121.8 (104.4) | 126.0 (72.9) | 0.15 |
| POPDI | 50 (36.7) | 52.1 (29.2) | 0.23 |
| CRADI | 21.9 (43.8) | 37.5 (31.3) | 0.10 |
| UDI | 41.7 (41.7) | 45.8 (41.7) | 0.48 |
| PFIQ-7 | 66.7 (95.2) | 48.8 (102.4) | 0.85 |
| POPIQ | 19.0 (47.6) | 21.4 (47.6) | 0.92 |
| CRAIQ | 9.5 (33.3) | 9.5 (33.3) | 0.66 |
| UIQ | 31.0 (46.8) | 28.6 (37.6) | 0.77 |
*
Data presented as n (%) unless otherwise noted
IQR, interquartile range; COPD, chronic obstructive pulmonary disease; POP-Q, pelvic organ prolapse quantification; PFDI-20, pelvic floor distress inventory-20; POPDI, pelvic organ prolapse distress inventory; CRADI, colorectal-anal distress inventory; UDI, urogenital distress inventory; PFIQ-7, pelvic floor impact questionnaire-7; POPIQ, pelvic organ prolapse impact questionnaire; CRAIQ, colorectal-anal impact questionnaire; UIQ, urogenital impact questionnaire